Treace Medical Concepts, Inc. Increase Decrease In Operating Lease Liability
Treace Medical Concepts, Inc. (TMCI) reported Increase Decrease In Operating Lease Liability of -$1.68 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOperatingLeaseLiability · last filed 2026-08-07
- Treace Medical Concepts, Inc. increase decrease in operating lease liability for the quarter ending 2026-06-30 was -$829.00K.
- Treace Medical Concepts, Inc. increase decrease in operating lease liability for the quarter ending 2026-03-31 was -$854.00K.
- Treace Medical Concepts, Inc. increase decrease in operating lease liability for the quarter ending 2025-12-31 was -$825.00K.
- Treace Medical Concepts, Inc. increase decrease in operating lease liability for the quarter ending 2025-09-30 was -$829.00K, a 172.47% decline year-over-year.
- Treace Medical Concepts, Inc. increase decrease in operating lease liability for fiscal 2025 was -$3.21M.
- Treace Medical Concepts, Inc. increase decrease in operating lease liability for fiscal 2024 was -$2.47M.
- Treace Medical Concepts, Inc. increase decrease in operating lease liability for fiscal 2023 was -$119.00K, a 103.87% decline from fiscal 2022.
- Treace Medical Concepts, Inc. increase decrease in operating lease liability for fiscal 2022 was $3.08M.
| Period end | Increase Decrease In Operating Lease Liability 3 month | Increase Decrease In Operating Lease Liability 6 month | Increase Decrease In Operating Lease Liability 9 month | Increase Decrease In Operating Lease Liability 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$829.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$1.68M 10-Q · filed 2026-08-07 | -$2.51M derived: sum of 3 quarters · filed 2026-08-07 | -$3.34M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$854.00K 10-Q · filed 2026-05-08 | -$1.68M derived: sum of 2 quarters · filed 2026-05-08 | -$2.51M derived: sum of 3 quarters · filed 2026-05-08 | -$3.28M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | -$825.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.65M derived: sum of 2 quarters · filed 2026-02-27 | -$2.42M derived: sum of 3 quarters · filed 2026-08-07 | -$3.21M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$829.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$1.60M derived: sum of 2 quarters · filed 2026-08-07 | -$2.38M 10-Q · filed 2025-11-06 | -$4.71M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | -$768.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$1.55M 10-Q · filed 2026-08-07 | -$3.88M derived: sum of 3 quarters · filed 2026-08-07 | -$2.73M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$785.00K 10-Q · filed 2026-05-08 | -$3.11M derived: sum of 2 quarters · filed 2026-05-08 | -$1.97M derived: sum of 3 quarters · filed 2026-05-08 | -$2.60M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$2.33M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.18M derived: sum of 2 quarters · filed 2026-02-27 | -$1.82M derived: sum of 3 quarters · filed 2026-02-27 | -$2.47M 10-K · filed 2026-02-27 |
| 2024-09-30 | $1.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $510.00K derived: sum of 2 quarters · filed 2025-11-06 | -$147.00K 10-Q · filed 2025-11-06 | -$763.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$634.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.29M 10-Q · filed 2025-08-07 | -$1.91M derived: sum of 3 quarters · filed 2026-02-27 | -$2.48M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$657.00K 10-Q · filed 2025-05-08 | -$1.27M derived: sum of 2 quarters · filed 2026-02-27 | -$1.85M derived: sum of 3 quarters · filed 2026-02-27 | -$298.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$616.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.19M derived: sum of 2 quarters · filed 2026-02-27 | $359.00K derived: sum of 3 quarters · filed 2026-02-27 | -$119.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | -$575.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $975.00K derived: sum of 2 quarters · filed 2024-11-05 | $497.00K 10-Q · filed 2024-11-05 | $461.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $1.07M 10-Q · filed 2024-08-06 | $1.04M derived: sum of 3 quarters · filed 2025-02-27 | $1.76M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$478.00K 10-Q · filed 2024-05-07 | -$514.00K derived: sum of 2 quarters · filed 2025-02-27 | $206.00K derived: sum of 3 quarters · filed 2025-02-27 | $2.73M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$36.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $684.00K derived: sum of 2 quarters · filed 2025-02-27 | $3.21M derived: sum of 3 quarters · filed 2025-02-27 | $3.08M 10-K · filed 2025-02-27 |
| 2022-09-30 | $720.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $3.25M derived: sum of 2 quarters · filed 2022-11-09 | $3.11M 10-Q · filed 2022-11-09 | $3.11M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-06-30 | $2.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $2.39M 10-Q · filed 2022-08-10 | $2.39M derived: sum of 3 quarters · filed 2023-05-09 | $2.39M derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-03-31 | -$133.00K 10-Q · filed 2023-05-09 | -$133.00K derived: sum of 2 quarters · filed 2023-05-09 | -$133.00K derived: sum of 3 quarters · filed 2023-05-09 | -$133.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $0.00 derived: sum of 2 quarters · filed 2023-03-08 | $0.00 derived: sum of 3 quarters · filed 2023-03-08 | $0.00 10-K · filed 2023-03-08 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | $0.00 10-Q · filed 2022-08-10 | ||
| 2021-03-31 | $0.00 10-Q · filed 2022-05-06 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |